Jared Silver
Overview
Explore the profile of Jared Silver including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wechsler M, Silver J, Wolff G, Price R, Verghis R, Weller P, et al.
Arthritis Rheumatol
. 2025 Feb;
PMID: 40008472
Objectives: Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare, relapsing, inflammatory disease. Management of EGPA predominantly relies on oral corticosteroids (OCS), which are associated with many adverse effects. The Phase...
2.
Pfaar O, Peters A, Taille C, Teeling T, Silver J, Chan R, et al.
Clin Transl Allergy
. 2025 Jan;
15(1):e70010.
PMID: 39794887
Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) is a recurrent inflammatory disease associated with several comorbidities and a significant disease burden for patients. Treatments include corticosteroids and sinonasal surgery, but...
3.
Mathur S, Silver J, MacKnight S, Urosevic A, Martinez C, Zhang K, et al.
Ann Allergy Asthma Immunol
. 2024 Nov;
134(3):341-350.e2.
PMID: 39549986
Background: Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare, chronic inflammatory disease characterized by asthma and small/medium vessel vasculitis. Mepolizumab is approved for use in EGPA disease management alongside oral...
4.
Han J, Silver J, Dhangar I, Veeranki P, Deb A
Ann Allergy Asthma Immunol
. 2024 Oct;
PMID: 39428097
Background: Real-world burden data on systemic corticosteroid (SCS) use in chronic rhinosinusitis with nasal polyps (CRSwNP) are limited. Objective: To describe the real-world burden of SCS in CRSwNP. Methods: This...
5.
Luong A, Levy J, Klimek L, Harvey R, Silver J, Smith S, et al.
J Allergy Clin Immunol Glob
. 2024 Oct;
3(4):100327.
PMID: 39380981
Background: In the phase III SYNAPSE study, mepolizumab plus standard of care reduced total endoscopic nasal polyp score (NPS) versus that with placebo in patients with chronic rhinosinusitis with nasal...
6.
Bernstein J, Silver J, Packnett E, Lew C, Robles Y, Deb A
Ann Allergy Asthma Immunol
. 2024 Jul;
133(4):422-429.e2.
PMID: 38972449
Background: Nasal polyps (NPs) are commonly associated with chronic rhinosinusitis (CRS). In keeping with the unified airway hypothesis, asthma and CRS with NP (CRSwNP) frequently co-occur, share a similar pathophysiology,...
7.
Silver J, Steffens A, Chastek B, Deb A
J Asthma Allergy
. 2024 Mar;
17:261-271.
PMID: 38544676
Purpose: Real-world data on mepolizumab in patients with severe asthma and allergic and non-allergic phenotypes are limited. This study investigated the effectiveness of mepolizumab treatment in patients with severe asthma...
8.
Silver J, Packnett E, Park J, Deb A
Allergy Asthma Clin Immunol
. 2023 Dec;
19(1):104.
PMID: 38066550
Background: Several biologics are now approved in the US as add-on treatments for chronic rhinosinusitus with nasal polyps (CRSwNP). This cross-sectional, retrospective, real-world study aimed to characterize treatment patterns and...
9.
Silver J, Deb A, Packnett E, McMorrow D, Morrow C, Bogart M
J Clin Rheumatol
. 2023 Oct;
29(8):381-387.
PMID: 37779234
Background/objective: Although the high disease burden associated with eosinophilic granulomatosis with polyangiitis (EGPA) has been established, the disease burden in patients initiating mepolizumab in real-world practice is poorly understood. This...
10.
Bloom J, Pickett-Nairn K, Silveira L, Fuhlbrigge R, Cuthbertson D, Akuthota P, et al.
Arthritis Rheumatol
. 2023 Jul;
75(12):2216-2227.
PMID: 37433067
Objective: This study examined the relationship between age at diagnosis and disease characteristics and damage in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Methods: Analysis of a prospective longitudinal...